Skip to main content
Clinical Trials/DRKS00022930
DRKS00022930
Not yet recruiting
Not Applicable

Study to identify blood-derived biomarkers indicative for initiation and progression of X-linked adrenoleukodystrophy

Center for Brain Research, Medical University of Vienna0 sites400 target enrollmentAugust 24, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Healthy volunteers
Sponsor
Center for Brain Research, Medical University of Vienna
Enrollment
400
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 24, 2020
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Center for Brain Research, Medical University of Vienna

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria for plasma/serum remnant samples from X\-ALD patients are:
  • 1\) diagnosis of X\-ALD by measurement of very long\-chain fatty acids in the blood
  • 2\) patient details (sex and age) are known at time of blood donation
  • 3\) available data on the clinical course of the disease
  • 4\) knowledge on medication and supplementation of the patient
  • Inclusion criteria for plasma/serum remnant samples from healthy controls are:
  • 1\) patient details (sex and age) are known at time of blood donation
  • 2\) no diagnosis of X\-ALD or other disorders associated with neurodegeneration or neuroinflammation

Exclusion Criteria

  • Exclusion criteria for plasma/serum remnant samples from X\-ALD patients and controls are:
  • Intake of lipid lowering and anti\-inflammatory medication

Outcomes

Primary Outcomes

Not specified

Similar Trials